Implantable peripheral nerve stimulation for chronic pain: a systematic review and meta-analysis of analgesic outcomes up to 24 months
Open Access
- 5 November 2025
- journal article
- review article
- Published by BMJ in Regional Anesthesia & Pain Medicine
Abstract
Background: Peripheral nerve stimulation (PNS) has emerged as a promising neurostimulation modality, yet its effectiveness and durability for chronic pain remain uncertain. We conducted a systematic review and meta-analysis to evaluate changes in pain intensity following implantable PNS therapy. Methods: Eligible studies included adults (≥18 years) with chronic pain treated with an implantable PNS system, and pain intensity was assessed at baseline and follow-up time points. The primary outcome was change in pain intensity from baseline to 6 months after PNS implantation. Secondary outcomes included changes in pain intensity at 3, 12 and 24 months after PNS implantation. Standardized mean differences (Hedges’ g ) were pooled using a random-effects model. Results: A total of 106 studies comprising 9272 patients were included. PNS was associated with large, statistically significant reductions in pain intensity from baseline to all time points: 3 months (Hedges’ g 2.92; 95% CI 2.62 to 3.21), 6 months (Hedges’ g 3.08; 95% CI 2.68 to 3.48), 12 months (Hedges’ g 2.68; 95% CI 2.30 to 3.05) and 24 months (Hedges’ g 2.08; 95% CI 1.68 to 2.48) (all p<0.001). However, the certainty of evidence as assessed by the Grading of Recommendations Assessment, Development and Evaluation criteria was rated as low for the primary outcome, due to pooling from observational studies, risk of bias, and heterogeneity (statistical, clinical and methodological). Subgroup analyses revealed no differences by study design or device type, while smaller effect sizes were reported in industry-funded studies and those with declared conflicts of interest. The largest effect sizes were observed in pelvic and upper extremity pain, whereas the smallest in truncal pain. Conclusion: Implantable PNS provides persistent and clinically meaningful analgesia for chronic pain, with benefits sustained up to 24 months. These findings support broader clinical adoption and provide evidence to inform pay0r coverage and policy decisions.Keywords
This publication has 41 references indexed in Scilit:
- Randomized Clinical Trials on Neurostimulation for Chronic Pain: Do They Comply With the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) Criteria?Neuromodulation: Technology at the Neural Interface, 2025
- Comparison of Two Different Neuromodulation Treatments in Patients With Acute Zoster-Related Trigeminal Neuropathic Pain and Pain CatastrophizingNeuromodulation: Technology at the Neural Interface, 2025
- Peripheral Percutaneous Electrical Nerve Stimulation for Neuropathies: A Systematic Review and Meta-analysisPain Management Nursing, 2024
- Clinical pain management: Current practice and recent innovations in researchCell Reports Medicine, 2024
- Two Decades of Declining Medicare Reimbursement in Cardiac SurgeryThe Annals of Thoracic Surgery, 2023
- Peripheral Nerve Stimulation for Low Back Pain: A Systematic ReviewCurrent Pain and Headache Reports, 2023
- Patient Satisfaction With Spinal Cord Stimulation and Dorsal Root Ganglion Stimulation for Chronic Intractable Pain: A Systematic Review and Meta-AnalysisNeuromodulation: Technology at the Neural Interface, 2022
- Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trialThe Lancet Neurology, 2021
- Mechanism of Action of Peripheral Nerve StimulationCurrent Pain and Headache Reports, 2021
- Core outcome measures for chronic pain clinical trials: IMMPACT recommendationsPain, 2005